Abstract
Although meningitis due to Staphylococcus aureus is uncommon today in infants and children, it remains an important pathogen1), particularly in catheter-associated infections. In cerebrospinal fluid (CSF) shunt infections, S. aureus accounts for approximately one quarter of infections2,3) Optimal antimicrobial therapy of that infection and of other infections of the central nervous system due to S, aureus is problematic, particularly for disease due to methicillin (DMPPC)-resistant strains4, 5).
| Original language | English |
|---|---|
| Pages (from-to) | 2155-2162 |
| Number of pages | 8 |
| Journal | Japanese Journal of Antibiotics |
| Volume | 38 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - 1985 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- General Medicine
- Microbiology (medical)
- Pharmacology (medical)
- Infectious Diseases
Fingerprint
Dive into the research topics of 'Bacteriological Efficacy of Nafcillin and Vancomycin Alone or Combined with Rifampicin or Amikacin in Experimental Meningitis Due to Methicillin-Susceptible or -Resistant Staphylococcus Aureus'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS